Literature DB >> 7856732

Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.

A B Kulkarni1, J M Ward, L Yaswen, C L Mackall, S R Bauer, C G Huh, R E Gress, S Karlsson.   

Abstract

Approximately 40% of transforming growth factor-beta 1 null (knockout) mice generated in our laboratory develop normally to term, but 60% die in utero. The animals appear normal during the first 2 weeks of life but develop a rapid wasting syndrome and die by 3 to 4 weeks of age. All of the knockout mice have a multifocal inflammatory disease in many tissues. The heart and lungs are most severely affected. Increased adhesion of leukocytes to the endothelium of pulmonary veins is the initial lesion seen at day 8 postnatally and is soon followed by perivascular cuffing as well as inflammatory infiltrates in lung parenchyma. The lesions in the heart begin as endocarditis and then progress to myocarditis and pericarditis. Within the lung, chronic inflammatory infiltrates consist of T and B lymphocytes, including plasma cells, whereas macrophages are the primary inflammatory cell type in the heart. Increased expression of major histocompatibility complex class I and II proteins is seen in pulmonary vascular endothelium as early as day 8. An immunoblastic response in mediastinal and mandibular lymph nodes and spleen is also seen. In the absence of any pathogens, this massive inflammatory disease, together with overexpression of major histocompatibility complex class I and II proteins and overproduction of immunoglobulins by lymphocytes, offers circumstantial evidence for an autoimmune etiology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856732      PMCID: PMC1870760     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Immune dysregulation in TGF-beta 1-deficient mice.

Authors:  M Christ; N L McCartney-Francis; A B Kulkarni; J M Ward; D E Mizel; C L Mackall; R E Gress; K L Hines; H Tian; S Karlsson
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

3.  Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.

Authors:  A P Kuruvilla; R Shah; G M Hochwald; H D Liggitt; M A Palladino; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

Authors:  L D Johns; K C Flanders; G E Ranges; S Sriram
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

5.  Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

Authors:  M K Racke; S Dhib-Jalbut; B Cannella; P S Albert; C S Raine; D E McFarlin
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

6.  B220: a B cell-specific member of th T200 glycoprotein family.

Authors:  R L Coffman; I L Weissman
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

7.  Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens.

Authors:  T Springer; G Galfrè; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

8.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

Review 9.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  44 in total

Review 1.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

Review 2.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

3.  Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.

Authors:  Chunsun Dai; Xiaoyan Wen; Weichun He; Youhua Liu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

4.  TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria.

Authors:  O V Horst; K A Tompkins; S R Coats; P H Braham; R P Darveau; B A Dale
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

5.  Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis.

Authors:  Xi Qiao; Padmashree Rao; Yun Zhang; Lixin Liu; Min Pang; Hailong Wang; Min Hu; Xinrui Tian; Jianlin Zhang; Ye Zhao; Xin Maggie Wang; Chengshi Wang; Hong Yu; Fei Guo; Qi Cao; Yiping Wang; Yuan Min Wang; Geoff Yu Zhang; Vincent W Lee; Stephen I Alexander; Guoping Zheng; David C H Harris
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

6.  Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice.

Authors:  Jennifer Nancy Hahn; Vincent George Falck; Frank Robert Jirik
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

7.  Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.

Authors:  M E Harris-White; T Chu; Z Balverde; J J Sigel; K C Flanders; S A Frautschy
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 8.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

Review 9.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

10.  The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schönlein purpura.

Authors:  Yao-Hsu Yang; Huey-Jen Lai; Cheng-Kai Kao; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Pediatr Nephrol       Date:  2004-07-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.